Molecular mechanisms of antibiotic resistance, Chem. Commun, vol.47, pp.4055-4061, 2011. ,
Mechanisms of antibiotic resistance, Front. Microbiol, vol.6, pp.1-3, 2015. ,
Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects, Food Technol. Biotechnol, vol.46, pp.11-21, 2008. ,
Antibiotic efflux mechanism, Curr. Opin. Infect. Dis, vol.12, pp.529-536, 1999. ,
The importance of efflux pumps in bacterial antibiotic resistance, J. Antimicrob. Chemother, vol.51, pp.9-11, 2003. ,
Drug efflux proteins in multidrug resistant bacteria, Biol. Chem, vol.378, pp.769-777, 1997. ,
Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions, Int. J. Med. Microbiol, vol.303, pp.287-292, 2013. ,
Multidrug-resistance efflux pumps? not just for resistance, Nat. Rev. Microbiol, vol.4, pp.629-636, 2006. ,
Proton-dependent multidrug efflux systems, Microbiol. Rev, vol.60, pp.575-608, 1996. ,
The antibiotic resistome: the nexus of chemical and genetic diversity, Nat. Rev. Microbiol, vol.5, pp.175-186, 2007. ,
Attacking the Enemy: Antimicrobial Agents and Chemotherapy: Macrolides, Medical Microbiology, p.489, 2004. ,
Molecular mechanisms that confer antibacterial drug resistance, Nature, vol.406, pp.775-781, 2000. ,
Action and resistance mechanisms of antibiotics: A guide for clinicians, J. Anaesthesiol. Clin. Pharmacol, vol.33, pp.300-305, 2017. ,
Plasmid-determined AmpC-type ?-lactamases ,
, Antimicrob. Agents Chemother, vol.46, pp.1-11, 2002.
Extended-spectrum ?-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat, Clin. Microbiol. Rev, vol.14, pp.933-951, 2001. ,
Extended-spectrum ?-lactamases (ESBLs): characterization, epidemiology and detection, Crit. Rev. Microbiol, vol.30, pp.25-32, 2004. ,
Antibiotic resistance mechanisms of clinically important bacteria, vol.47, pp.137-146, 2011. ,
Molecular mechanisms of antibacterial multidrug resistance, Cell, vol.128, pp.1037-1050, 2007. ,
, , 2007.
Mechanisms of antibiotic resistance and delivery strategies to prevent its emergence, J. Drug Deliv. Sci. Technol, vol.20, pp.407-418, 2010. ,
Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa, Microbiology, vol.145, pp.2857-286, 1999. ,
The origins and molecular basis of antibiotic resistance, Br. Med. J, vol.317, pp.657-660, 1998. ,
Predictable and unpredictable evolution of antibiotic resistance, J. Intern. Med, vol.264, pp.4-16, 2008. ,
Antibacterial resistance worldwide: causes, challenges and responses, Nat. Med, vol.10, pp.122-129, 2004. ,
Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria, Br. J. Pharmacol, vol.153, pp.347-357, 2008. ,
Antimicrobial resistance of Staphylococcus aureus: genetic basis, Microbiol. Rev, vol.51, pp.88-134, 1987. ,
Antibiotic hybrids: the next generation of agents and adjuvants against Gram-negative pathogens?, Clin. Microbiol. Rev, vol.31, pp.77-94, 2018. ,
Antibiotic combinations: should they be tested?, Clin. Microbiol. Rev, vol.1, pp.139-156, 1988. ,
Antibiotic adjuvants: rescuing antibiotics from resistance, Trends Microbiol, vol.24, pp.862-871, 2016. ,
Therapeutic strategies to combat antibiotic resistance, Adv. Drug Del. Rev, vol.78, pp.14-27, 2014. ,
Antibiotic adjuvants-A strategy to unlock bacterial resistance to antibiotics, Bioorg. Med. Chem. Lett, vol.27, pp.4221-4228, 2017. ,
Antibiotic adjuvants: multicomponent anti-infective strategies, Expert Rev. Mol. Med, 2011. ,
Reservoirs of resistance: To understand why antibiotics fail, geneticists chase the 'resistome', Nat. Med, vol.22, pp.1069-1071, 2016. ,
The challenge of overcoming antibiotic resistance: an adjuvant approach? ACS infectious diseases, vol.3, pp.559-563, 2017. ,
Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities, Int. J. Antimicrob. Agents, vol.31, pp.198-208, 2008. ,
The potential management of resistant infections with nonantibiotics, The Journal of antimicrobial chemotherapy, vol.40, pp.319-327, 1997. ,
Effects of chlorpromazine on the cell envelope proteins of Escherichia coli, Antimicrob. Agents Chemother, vol.35, pp.1923-1924, 1991. ,
Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium, Int. J. Antimicrob. Agents, vol.30, pp.242-249, 2007. ,
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps, J. Antimicrob. Chemother, vol.59, pp.1237-1246, 2007. ,
Beta-lactamase inhibitors from laboratory to clinic, Clin. Microbiol. Rev, vol.1, pp.109-123, 1988. ,
, Drug Resistance Updates, vol.3, pp.109-125, 2000.
?-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone, Clin. Infect. Dis, vol.24, pp.494-497, 1997. ,
New ?-lactam-?-lactamase inhibitor combinations in clinical development ,
, Ann. N.Y. Acad. Sci, vol.1277, pp.105-114, 2013.
Augmentin (amoxicillin/clavulanate) in the treatment of communityacquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent, J. Antimicrob. Chemother, vol.53, pp.3-20, 2004. ,
Three decades of beta-lactamase inhibitors, Clin. Microbiol. Rev, vol.23, pp.160-201, 2010. ,
Evolution and epidemiology of extendedspectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms, Clin. Microbiol. Infect, vol.7, pp.597-608, 2001. ,
Extended-spectrum beta-lactamases: a clinical update, Clin. Microbiol. Rev, vol.18, pp.657-686, 2005. ,
Antibiotic adjuvants: rescuing antibiotics from resistance, Trends Microbiol, vol.24, pp.862-871, 2016. ,
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens, Chem. Biol. Drug Des, vol.85, pp.56-78, 2015. ,
Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance, Curr. Opin. Pharmacol, vol.12, pp.551-555, 2012. ,
Antibiotic adjuvants: multicomponent antiinfective strategies, Expert Rev. Mol. Med, 2011. ,
Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates, vol.128, pp.68-71, 2017. ,
CP-45,899, a betalactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization, Antimicrob. Agents Chemother, vol.14, pp.414-419, 1978. ,
In vitro activity of AVE1330A, an innovative broadspectrum non-?-lactam ?-lactamase inhibitor, J. Antimicrob. Chemother, vol.54, pp.410-417, 2004. ,
Cyclic boronates inhibit all classes of ?-lactamases, Antimicrob. Agents Chemother, vol.61, pp.2260-02216, 2017. ,
Aspergillomarasmine A overcomes metallobeta-lactamase antibiotic resistance, Nature, vol.510, pp.503-506, 2014. ,
Total synthesis and activity of the metallo-beta-lactamase inhibitor aspergillomarasmine A, Angew. Chem. Int. Ed. Engl, vol.55, pp.2210-2212, 2016. ,
Total synthesis of aspergillomarasmine A and related compounds: a sulfamidate approach enables exploration of structure-activity relationships, Angew. Chem. Int. Ed. Engl, vol.55, pp.13259-13262, 2016. ,
Imipenem-cilastatin: the first thienamycin antibiotic, Pediatr. Infect. Dis, vol.5, pp.444-448, 1986. ,
Aspergillomarasmine A, an Inhibitor of Bacterial Metallo?-Lactamases Conferring blaNDM and blaVIM Resistance, Angew. Chem. Int. Ed. Engl, vol.53, pp.11696-11698, 2014. ,
Discovery of MK-7655, a ?-lactamase inhibitor for combination with Primaxin®, Bioorg. Med. Chem. Lett, vol.24, pp.780-785, 2014. ,
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy, J. Antimicrob. Chemother, vol.51, pp.1055-1065, 2003. ,
,
Microbial efflux pump inhibition: tactics and strategies, Curr. Pharm. Des, vol.17, pp.1291-1302, 2011. ,
Inhibitors of multidrug resistant efflux systems in bacteria, Recent Pat. Antiinfect Drug Discov, vol.4, pp.37-50, 2009. ,
Efflux-mediated drug resistance in bacteria, Drugs, vol.64, pp.159-204, 2004. ,
Efflux-mediated antimicrobial resistance, J. Antimicrob. Chemother, vol.56, pp.20-51, 2005. ,
Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria, PLoS One, vol.6, 2011. ,
Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy, Recent Pat. Antiinfect Drug Discov, vol.7, pp.73-89, 2012. ,
Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria, FEBS Lett, vol.585, pp.1682-1690, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01425039
Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux, Recent Pat. Antiinfect Drug Discov, vol.1, pp.157-175, 2006. ,
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria, Clin. Microbiol. Rev, vol.19, pp.382-402, 2006. ,
Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrugresistant clinical isolates, Biochem. J, vol.376, pp.801-805, 2003. ,
Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa, BMC Complement. Altern. Med, vol.17, p.405, 2017. ,
Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance, Bioorg. Med. Chem. Lett, vol.27, pp.733-739, 2017. ,
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3, 4-dibromopyrrole-2, 5-dione isolated from a Pseudoalteromonas sp, J. Nat. Prod, vol.78, pp.402-412, 2015. ,
, An efflux pump
, of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG), Phytomedicine, vol.36, pp.194-200, 2017.
Outer membrane permeability and antibiotic resistance, Biochim. Biophys. Acta, vol.1794, pp.808-816, 2009. ,
Molecular basis of bacterial outer membrane permeability revisited. Microbiol, Mol. Biol. Rev, vol.67, pp.593-656, 2003. ,
Structural insights into outer membrane permeability of Acinetobacter baumannii, Structure, vol.24, pp.221-231, 2016. ,
Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria, FEBS Lett, vol.585, pp.1682-1690, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01425039
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections, Nat. Rev. Microbiol, vol.9, pp.62-75, 2011. ,
Synthetic membrane-targeted antibiotics, Curr. Med. Chem, vol.17, pp.2292-2300, 2010. ,
Resistance to polymyxins: mechanisms, frequency and treatment options. Drug resistance updates, vol.13, pp.132-138, 2010. ,
Polymyxins and their novel derivatives, Curr. Opin. Microbiol, vol.13, pp.574-581, 2010. ,
Antibacterial activities and membrane permeability actions of glycinin basic peptide against Escherichia coli, Innov. Food Sci. Emerg. Technol, vol.31, pp.170-176, 2015. ,
Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism, Saudi J. Biol. Sci, vol.24, pp.59-64, 2017. ,
,
, Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: its effects on bacterial outer membrane permeability and efflux pumps, Microbiol. Res, vol.169, pp.417-424, 2014.
Antimicrobial peptides: general overview and clinical implications in human health and disease, Clin. Immunol, vol.135, pp.1-11, 2010. ,
Spotlight on human LL-37, an immunomodulatory peptide with promising cell-penetrating properties, Pharmaceuticals, vol.3, pp.3435-3460, 2010. ,
Synthesis and Characterization of Peptide? Cationic Steroid Antibiotic Conjugates, Org. Lett, vol.6, pp.3433-3436, 2004. ,
The bacterial envelope as a target for novel anti-MRSA antibiotics, Trends Pharmacol. Sci, vol.29, pp.124-134, 2008. ,
Ceragenins: cholic acid-based mimics of antimicrobial peptides, Acc. Chem. Res, vol.41, pp.1233-1240, 2008. ,
Peptide antimicrobial agents, Clin. Microbiol. Rev, vol.19, pp.491-511, 2006. ,
Cathelicidins-a family of multifunctional antimicrobial peptides, Cell ,
Design and synthesis of potent sensitizers of Gram-negative bacteria based on a cholic acid scaffolding, J. Am. Chem. Soc, vol.120, pp.2961-2962, 1998. ,
Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents, Drug News Perspect, vol.21, pp.307-311, 2008. ,
Ceragenins-a new weapon to fight multidrug resistant bacterial infections, Medical Studies, vol.30, pp.207-213, 2014. ,
Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics, J. Med. Chem, vol.45, pp.663-669, 2002. ,
Antimicrobial activities of squalamine mimics, Antimicrob. Agents Chemother, vol.41, pp.1433-1438, 1997. ,
Antimicrobial activities of amine-and guanidine-functionalized cholic acid derivatives, Antimicrob. Agents Chemother, vol.43, pp.1347-1349, 1999. ,
Incremental conversion of outer-membrane permeabilizers into potent antibiotics for Gramnegative bacteria, J. Am. Chem. Soc, vol.121, pp.931-940, 1999. ,
Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus, Antimicrob. Agents Chemother, vol.51, pp.1268-1273, 2007. ,
Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients, BioMed Res. Int, p.710273, 2014. ,
Mode of action of novel polyamines increasing the permeability of bacterial outer membrane, Int. J. Antimicrob. Agents, vol.24, pp.67-71, 2004. ,
Interaction between polyamines and bacterial outer membranes as investigated with ion-selective electrodes, Antimicrob. Agents Chemother, vol.46, pp.1073-1079, 2002. ,
Agents that increase the permeability of the outer membrane, Microbiol. Rev, vol.56, pp.395-411, 1992. ,
Outer membrane, Escherichia coli and Salmonella. Cell. Mol. Biol, pp.29-47, 1996. ,
Potassium and tetraphenylphosphonium ion-selective electrodes for monitoring changes in the permeability of bacterial outer and cytoplasmic membranes, J. Microbiol. Methods, vol.54, pp.111-115, 2003. ,
Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?, PLoS One, vol.3, p.2765, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00400776
Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria, J. Antimicrob. Chemother, vol.65, pp.799-801, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00465656
Claramines: A new class of broad-spectrum antimicrobial agents with bimodal activity, ChemMedChem, vol.13, pp.1018-1027, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02110834
Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria, vol.18, pp.276-283, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01789352
New Ianthelliformisamine derivatives as antibiotic enhancers against resistant Gram-negative bacteria, J. Med. Chem, vol.57, pp.4263-4272, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01460535
Polyamino geranic derivatives as new chemosensitizers to combat antibiotic resistant Gram-negative bacteria, Biorg. Med. Chem, vol.21, pp.1174-1179, 2013. ,
Polyamino-isoprenic derivatives block intrinsic resistance of P. aeruginosa to doxycycline and chloramphenicol in vitro, PLoS One, vol.11, p.154490, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01463102